Gehan H. Heeba

1.8k total citations
50 papers, 1.5k citations indexed

About

Gehan H. Heeba is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Gehan H. Heeba has authored 50 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Pathology and Forensic Medicine and 13 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Gehan H. Heeba's work include Heme Oxygenase-1 and Carbon Monoxide (7 papers), Liver Disease Diagnosis and Treatment (6 papers) and Diet, Metabolism, and Disease (6 papers). Gehan H. Heeba is often cited by papers focused on Heme Oxygenase-1 and Carbon Monoxide (7 papers), Liver Disease Diagnosis and Treatment (6 papers) and Diet, Metabolism, and Disease (6 papers). Gehan H. Heeba collaborates with scholars based in Egypt, United Arab Emirates and United States. Gehan H. Heeba's co-authors include Alaaeldin Ahmed Hamza, Magda E. Mahmoud, Mohamed A. Morsy, Amr Amin, Ashraf Taye, Mohamed Mansour Khalifa, Rania Abdellatif, Mohamed A. El‐Moselhy, Soha Osama Hassanin and Tadeusz Maliñski and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Gehan H. Heeba

48 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gehan H. Heeba Egypt 25 458 233 207 200 184 50 1.5k
Mona F. Schaalan Egypt 22 443 1.0× 284 1.2× 100 0.5× 169 0.8× 143 0.8× 65 1.4k
Ke Fang China 22 603 1.3× 260 1.1× 170 0.8× 172 0.9× 101 0.5× 48 1.4k
Vivian Soetikno Indonesia 23 616 1.3× 361 1.5× 104 0.5× 165 0.8× 164 0.9× 67 1.8k
Hamid Mollazadeh Iran 26 663 1.4× 179 0.8× 266 1.3× 179 0.9× 147 0.8× 49 2.0k
Salma Malik India 21 381 0.8× 170 0.7× 168 0.8× 116 0.6× 306 1.7× 43 1.4k
Suhuan Liu China 18 538 1.2× 396 1.7× 118 0.6× 249 1.2× 214 1.2× 31 1.5k
Mohammed M.H. Al-Gayyar Egypt 32 879 1.9× 143 0.6× 188 0.9× 146 0.7× 335 1.8× 94 2.4k
Jingping Ouyang China 22 733 1.6× 198 0.8× 127 0.6× 161 0.8× 92 0.5× 56 1.7k
Miaomiao Xi China 22 629 1.4× 155 0.7× 127 0.6× 118 0.6× 110 0.6× 36 1.3k
Guifen Qiang China 21 584 1.3× 188 0.8× 112 0.5× 171 0.9× 81 0.4× 56 1.3k

Countries citing papers authored by Gehan H. Heeba

Since Specialization
Citations

This map shows the geographic impact of Gehan H. Heeba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gehan H. Heeba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gehan H. Heeba more than expected).

Fields of papers citing papers by Gehan H. Heeba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gehan H. Heeba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gehan H. Heeba. The network helps show where Gehan H. Heeba may publish in the future.

Co-authorship network of co-authors of Gehan H. Heeba

This figure shows the co-authorship network connecting the top 25 collaborators of Gehan H. Heeba. A scholar is included among the top collaborators of Gehan H. Heeba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gehan H. Heeba. Gehan H. Heeba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hamza, Alaaeldin Ahmed, et al.. (2025). Gallic and glycyrrhetinic acids prevent azithromycin-induced liver damage in rats by mitigating oxidative stress and inflammation. Scientific Reports. 15(1). 9566–9566. 8 indexed citations
2.
Amin, Amr, et al.. (2024). Comparative effects of incretin-based therapy on doxorubicin-induced nephrotoxicity in rats: the role of SIRT1/Nrf2/NF-κB/TNF-α signaling pathways. Frontiers in Pharmacology. 15. 1353029–1353029. 24 indexed citations
3.
Othman, Eman M., et al.. (2023). Mechanistic Protective Effect of Cilostazol in Cisplatin-Induced Testicular Damage via Regulation of Oxidative Stress and TNF-α/NF-κB/Caspase-3 Pathways. International Journal of Molecular Sciences. 24(16). 12651–12651. 15 indexed citations
4.
Hamza, Alaaeldin Ahmed, et al.. (2023). Hibiscus-cisplatin combination treatment decreases liver toxicity in rats while increasing toxicity in lung cancer cells via oxidative stress- apoptosis pathway. Biomedicine & Pharmacotherapy. 165. 115148–115148. 34 indexed citations
5.
Heeba, Gehan H., et al.. (2021). Comparative effects of incretin-based therapy on early-onset diabetic nephropathy in rats: Role of TNF-α, TGF-β and c-caspase-3. Life Sciences. 278. 119624–119624. 10 indexed citations
6.
Abdellatif, Rania, et al.. (2020). Low-dose lixisenatide protects against early-onset nephropathy induced in diabetic rats. Life Sciences. 263. 118592–118592. 17 indexed citations
7.
Heeba, Gehan H., et al.. (2020). Effect of combined therapy of mesenchymal stem cells with GLP-1 receptor agonist, exenatide, on early-onset nephropathy induced in diabetic rats. European Journal of Pharmacology. 892. 173721–173721. 23 indexed citations
8.
Hamza, Alaaeldin Ahmed, et al.. (2020). Standardized extract of ginger ameliorates liver cancer by reducing proliferation and inducing apoptosis through inhibition oxidative stress/ inflammation pathway. Biomedicine & Pharmacotherapy. 134. 111102–111102. 106 indexed citations
9.
Heeba, Gehan H., et al.. (2019). Comparative effectiveness of phosphodiesterase 3, 4, and 5 inhibitors in amelioration of high‐fat diet‐induced nonalcoholic fatty liver in rats. Fundamental and Clinical Pharmacology. 34(3). 353–364. 8 indexed citations
10.
Abdellatif, Rania, Gehan H. Heeba, Ashraf Taye, & Mohamed Mansour Khalifa. (2018). Lixisenatide ameliorates cerebral ischemia-reperfusion injury via GLP-1 receptor dependent/independent pathways. European Journal of Pharmacology. 833. 145–154. 19 indexed citations
11.
Abdellatif, Rania, Gehan H. Heeba, Ashraf Taye, & Mohamed M. Khalifa. (2018). Lixisenatide, a novel GLP-1 analog, protects against cerebral ischemia/reperfusion injury in diabetic rats. Naunyn-Schmiedeberg s Archives of Pharmacology. 391(7). 705–717. 33 indexed citations
12.
Heeba, Gehan H. & Mohamed A. Morsy. (2015). Fucoidan ameliorates steatohepatitis and insulin resistance by suppressing oxidative stress and inflammatory cytokines in experimental non-alcoholic fatty liver disease. Environmental Toxicology and Pharmacology. 40(3). 907–914. 69 indexed citations
13.
Morsy, Mohamed A., Gehan H. Heeba, & Magda E. Mahmoud. (2015). Ameliorative effect of eprosartan on high-fat diet/streptozotocin-induced early diabetic nephropathy in rats. European Journal of Pharmacology. 750. 90–97. 21 indexed citations
14.
Heeba, Gehan H. & Magda E. Mahmoud. (2014). Therapeutic potential of morin against liver fibrosis in rats: Modulation of oxidative stress, cytokine production and nuclear factor kappa B. Environmental Toxicology and Pharmacology. 37(2). 662–671. 54 indexed citations
15.
Heeba, Gehan H. & Magda E. Mahmoud. (2014). Dual effects of quercetin in doxorubicin‐induced nephrotoxicity in rats and its modulation of the cytotoxic activity of doxorubicin on human carcinoma cells. Environmental Toxicology. 31(5). 624–636. 44 indexed citations
16.
Taye, Ashraf, et al.. (2013). Quercetin augments the protective effect of losartan against chronic doxorubicin cardiotoxicity in rats. Environmental Toxicology and Pharmacology. 36(2). 443–450. 64 indexed citations
17.
Heeba, Gehan H.. (2011). Angiotensin II Receptor Blocker, Losartan, Ameliorates Gentamicin-Induced Oxidative Stress and Nephrotoxicity in Rats. Pharmacology. 87(3-4). 232–240. 26 indexed citations
18.
Heeba, Gehan H., et al.. (2009). Anti‐atherogenic effect of statins: role of nitric oxide, peroxynitrite and haem oxygenase‐1. British Journal of Pharmacology. 156(8). 1256–1266. 60 indexed citations
19.
Heeba, Gehan H., et al.. (2009). Gastroprotective effect of simvastatin against indomethacin-induced gastric ulcer in rats: Role of nitric oxide and prostaglandins. European Journal of Pharmacology. 607(1-3). 188–193. 71 indexed citations
20.
Mason, R. Preston, Ruslan Kubant, Gehan H. Heeba, et al.. (2007). Synergistic Effect of Amlodipine and Atorvastatin in Reversing LDL-Induced Endothelial Dysfunction. Pharmaceutical Research. 25(8). 1798–1806. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mona F. Schaalan Breakdown of academic impact, for papers by Ke Fang Breakdown of academic impact, for papers by Vivian Soetikno Breakdown of academic impact, for papers by Hamid Mollazadeh Breakdown of academic impact, for papers by Salma Malik Breakdown of academic impact, for papers by Suhuan Liu Breakdown of academic impact, for papers by Mohammed M.H. Al-Gayyar Breakdown of academic impact, for papers by Jingping Ouyang Breakdown of academic impact, for papers by Miaomiao Xi Breakdown of academic impact, for papers by Guifen Qiang
Rankless by CCL
2026